2022 mid-year highlights in Canadian life sciences IP and re

In the first half of 2022, Rx IP Update reported on a number of developments in Canadian life sciences IP and regulatory law. The Rx IP Update team at Smart & Biggar has collected the...

Related Keywords

Canada , Quebec , Canadian , Janssenv Pharmascience , Janssenv Sandoz , Janssenv Apotex , Urszula Wojtyra , Alice Tseng , Pharmasciencev Teva , Meta Facebook , Allerganv Apotex , Instagram , Health Canada Forward Regulatory Plan , Quebec Court , Meta Platforms Inc , Facebook , Health Canada , Merck Sharp Dohme Corpv Pharmascience , Competition Bureau , Patented Medicines Regulationswere , Patented Medicines Regulations , Federal Court , Forward Regulatory Plan , Advanced Therapeutic Products Pathway , Adaptive Machine Learning Enabled Medical Devices , Drug Regulations , Final Report , Building Toward , Potential Pan Canadian Formulary , Federal Courts , Patented Medicines , Dohme Corp , Competition Act In June , Meta Platforms ,